SUMMARY Since quinidine is one of the few agents available to treat and prevent ventricular arrhythmias in am-bulatory patients, its hemodynamic effects have been re-evaluated. When given in therapeutic doses to anesthetized mongrel dogs, quinidine significantly reduced heart rate, aortic pressure and flow, but it did not significantly change the first derivative of the left ventricular pressure curve (left ventricular dp/dt) in nine dogs. A subsequent group of dogs was studied after vagotomy and practolol administration to block cardiac reflexes. This group showed significant reduc-tions in heart rate, aortic pressure and left ventricular dp/dt, OQUINIDINE is widely used to treat and prevent cardiac arrhythmias, and its hemodynamic effects...
BERGER, JAMES E. AND CORWIN M. MOKLER: The interaction of quinidine with alpha and beta adrenergic r...
Flecainide and other class IC antiarrhythmic drugs are effective in the prevention and termination o...
A single dose of 0.6 Gm. of quinidine sulfate was given by mouth to each of five patients with sinus...
The possibility that an asynchronous increase in the ventricular monophasic action potential duratio...
Experiments were performed on awake dogs with chronic recording elec-trodes implanted on the SA node...
Nawrath, Hermann: Action potential, membrane currents and force of contraction in mammalian heart mu...
Transmembrane electrical activity from endo- and epicardium and a high-gain ECG were recorded from i...
In dogs with myocardial infarction, produced by a standard technic, rapid persistent ectopic ventric...
Although metabolites of quinidine are active in animal models and can accumulate to plasma levels si...
Quinidine therapy is one of the most common causes of the acquired long QT syndrome and the morpholo...
Historically, quinidine was the first medicine used in the therapy of heart arrhythmias. Studies in ...
PK 1 01 39 is a new synthetic quinoline antiarrhythmic agent 10 times more potent and at least 2 to ...
Quinidine is the most commonly used drug for the chronic treatment of ventricular arrhythmias, but i...
Accumulating evidence suggest the underlying danger of Class IA and Class III antiarrhythmic agents ...
T HE observations t,o be described in this paper were made in con- nection with a study of auricular...
BERGER, JAMES E. AND CORWIN M. MOKLER: The interaction of quinidine with alpha and beta adrenergic r...
Flecainide and other class IC antiarrhythmic drugs are effective in the prevention and termination o...
A single dose of 0.6 Gm. of quinidine sulfate was given by mouth to each of five patients with sinus...
The possibility that an asynchronous increase in the ventricular monophasic action potential duratio...
Experiments were performed on awake dogs with chronic recording elec-trodes implanted on the SA node...
Nawrath, Hermann: Action potential, membrane currents and force of contraction in mammalian heart mu...
Transmembrane electrical activity from endo- and epicardium and a high-gain ECG were recorded from i...
In dogs with myocardial infarction, produced by a standard technic, rapid persistent ectopic ventric...
Although metabolites of quinidine are active in animal models and can accumulate to plasma levels si...
Quinidine therapy is one of the most common causes of the acquired long QT syndrome and the morpholo...
Historically, quinidine was the first medicine used in the therapy of heart arrhythmias. Studies in ...
PK 1 01 39 is a new synthetic quinoline antiarrhythmic agent 10 times more potent and at least 2 to ...
Quinidine is the most commonly used drug for the chronic treatment of ventricular arrhythmias, but i...
Accumulating evidence suggest the underlying danger of Class IA and Class III antiarrhythmic agents ...
T HE observations t,o be described in this paper were made in con- nection with a study of auricular...
BERGER, JAMES E. AND CORWIN M. MOKLER: The interaction of quinidine with alpha and beta adrenergic r...
Flecainide and other class IC antiarrhythmic drugs are effective in the prevention and termination o...
A single dose of 0.6 Gm. of quinidine sulfate was given by mouth to each of five patients with sinus...